Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jun Li, Ph.D
CONTACT
Yongping Song, Ph.D
CONTACT
Lead
Fundamenta Therapeutics, Ltd.
With
This is a phase 1, single-center, nonrandomized, open-label, dose-escalation study to evaluate the safety and efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in patients with CD19 positive r/r B-ALL and identify a treatment regimen most likely to result in clinical efficacy while maintaining a favorable safety profile.
Age
14–75
Sex
ALL
Healthy volunteers
Not accepted
